Anteris Technologies Global Corp. — Director's Dealing 2010

May 27, 2010

==> picture [595 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace bioMD Limited ABN 35 088 221 078 Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433

www.biomd.com.au

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 2 pages

28 May 2010

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice

The Directors of bioMD Ltd wish to advise of changes to the notifiable interests of a director in accordance with Listing Rule 3.19A.2 and section 205G of the Corporations Act.

Yours faithfully

==> picture [78 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [595 x 42] intentionally omitted <==

APPENDIX 3Y

CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 088 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Towner Date of last notice: 12 April 2010

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Direct / Indirect Nature of indirect interest: Mr Towner is a director of companies holding BODOA

Date of change: 19 May 2010 No. of securities held prior to change: 4,539,661 (indirect), 3,791,667 (direct) and 7,311,251 (nominee) Class: Options (BODOA) Number acquired: 8,833,333 options transferred to direct holding and 1,811,251 options to indirect holding from nominee entity Number disposed: 7,311,251 options transferred from nominee entity to direct and indirect holdings and 3,333,333 from indirect to direct holding Value/Consideration: Nil – no change to overall holdings No. of securities held after change: 3,017,579 (indirect) and 12,625,000 (direct) Nature of the change: Off market transfer between holdings PART 2 – Change of director’s interests in contracts Details of contract: None Applicable Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change: